dr. powles on monitoring immunotherapy effects in patients with rcc
Published 5 years ago • 292 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
1:33
dr. powles on the impact of immunotherapy in kidney cancer
-
1:40
dr. powles on fda approval of pembrolizumab plus axitinib in advanced rcc
-
2:16
dr. powles on biomarkers for immunotherapy in bladder cancer
-
1:02
dr. sznol on immunotherapy in patients with rcc
-
0:48
dr. pal on preoperative immunotherapy in patients with rcc
-
1:29
dr. sznol on unanswered questions with immunotherapy in rcc
-
1:17
dr. hammers on the future of immunotherapy in rcc
-
0:56
dr. hammers on next steps with immunotherapy in rcc
-
4:34
immunotherapy in renal cell carcinoma
-
1:52
dr. choueiri on using immunotherapy to treat rcc
-
2:05
dr. powles on potential for durvalumab in renal cancer
-
2:13
dr. amin on next steps with immunotherapy in advanced rcc
-
1:02
dr. choueiri on the research with immunotherapy in rcc
-
1:34
dr. powles on rationale for keynote-426 in mrcc
-
2:01
dr. nanus on managing side effects from immunotherapy in rcc
-
6:37
immunotherapy in kidney cancer
-
1:56
dr. cost on pembrolizumab plus axitinib in patients with rcc
-
0:50
dr. ball on eventual role of immunotherapy in patients with rcc
-
0:43
dr. rini on adjuvant immunotherapy in renal cell carcinoma